Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/05 → 31/12/20 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$851,980.00
- NHMRC - National Health and Medical Research Council (Australia): A$780,805.00
- NHMRC - National Health and Medical Research Council (Australia): A$707,500.00
- NHMRC - National Health and Medical Research Council (Australia): A$138,500.00
-
Tumour-specific phosphorylation of serine 419 drives alpha-enolase (ENO1) nuclear export in triple negative breast cancer progression
Marshall, M. L., Fung, K. Y. C., Jans, D. A. & Wagstaff, K. M., 7 Jun 2024, In: Cell & Bioscience. 14, 1, 22 p., 74.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Link opens in a new tab Citations (Scopus) -
Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus
Martin, A. J. (Leading Author), Shackleford, D. M., Charman, S. A., Wagstaff, K. M., Porter, C. J. H. & Jans, D. A. (Leading Author), Jul 2023, In: Pharmaceutics. 15, 7, 17 p., 1974.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
The Nuclear Transporter Importin 13 Can Regulate Stress-Induced Cell Death through the Clusterin/KU70 Axis
Gajewska, K. A., Jans, D. A. & Wagstaff, K. M., Jan 2023, In: Cells. 12, 2, 30 p., 279.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)